Literature DB >> 11440637

Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice.

C M Ahmed1, K N Wills, B J Sugarman, D E Johnson, M Ramachandra, T L Nagabhushan, J A Howe.   

Abstract

Replication-deficient adenoviruses expressing human interferon-alpha2b (HuIFN-alpha2b) or the hybrid IFN-alpha2alpha1 or those with the secretory signal deleted, whose express is driven by the alpha-fetoprotein (AFP) promoter, were constructed and characterized. Synthesis of IFN protein and secretion or intracellular retention were tested by Western blotting and immunoassay. Expression of IFN by the recombinant adenoviruses was restricted to cells that constitutively express AFP. In these cells, expression of both secreted and nonsecreted recombinant IFN resulted in inhibition of cell proliferation, resistance to viral infection, induction of major histocompatibility complex (MHC) class I expression, increased apoptosis, and activation of an IFN-stimulated response element (ISRE)-containing promoter. Also, the induction of protein kinase R (PKR), increased phosphorylation of Stat1, and accumulation of hypophosphorylated pRb were observed for both the secreted and nonsecreted IFN, suggesting that the nonsecreted IFN may act through a similar pathway. Hep3B cells, an AFP-positive line derived from a patient with hepatocellular carcinoma (HCC), were injected subcutaneously (s.c.) into athymic nude mice to generate established tumors. Intratumoral injection of recombinant adenoviruses expressing secreted as well as the nonsecreted IFN caused suppression of tumor growth. As the AFP promoter is activated in many HCC cells but is silent in normal cells, these constructs may be useful in restricting IFN effects to the tumor cells while reducing toxicity to the neighboring tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440637     DOI: 10.1089/107999001750277871

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  13 in total

1.  Type I interferon mimetics bypass vaccinia virus decoy receptor virulence factor for protection of mice against lethal infection.

Authors:  Chulbul M Ahmed; Howard M Johnson
Journal:  Clin Vaccine Immunol       Date:  2014-06-25

2.  Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling.

Authors:  Chulbul M I Ahmed; Rea Dabelic; James P Martin; Lindsey D Jager; S Mohammad Haider; Howard M Johnson
Journal:  J Immunol       Date:  2010-06-11       Impact factor: 5.422

3.  Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.

Authors:  Chulbul M I Ahmed; Marjorie A Burkhart; Prem S Subramaniam; Mustafa G Mujtaba; Howard M Johnson
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections.

Authors:  Chulbul M Ahmed; Howard M Johnson
Journal:  J Interferon Cytokine Res       Date:  2014-05-08       Impact factor: 2.607

5.  Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma.

Authors:  Candice L Willmon; Vassiliki Saloura; Zvi G Fridlender; Phonphimon Wongthida; Rosa Maria Diaz; Jill Thompson; Timothy Kottke; Mark Federspiel; Glen Barber; Steven M Albelda; Richard G Vile
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

6.  Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy.

Authors:  Chulbul M Ahmed; Ezra N Noon-Song; Kaisa Kemppainen; Massimo P Pascalli; Howard M Johnson
Journal:  J Neuroimmunol       Date:  2012-10-27       Impact factor: 3.478

Review 7.  The role of a non-canonical JAK-STAT pathway in IFN therapy of poxvirus infection and multiple sclerosis: An example of Occam's Broom?

Authors:  Chulbul M Ahmed; Howard M Johnson
Journal:  JAKSTAT       Date:  2013-09-04

8.  Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer.

Authors:  M Ohashi; K Yoshida; M Kushida; Y Miura; S Ohnami; Y Ikarashi; Y Kitade; T Yoshida; K Aoki
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

9.  IFN signaling: how a non-canonical model led to the development of IFN mimetics.

Authors:  Howard M Johnson; Ezra Neptune Noon-Song; Rea Dabelic; Chulbul M Ahmed
Journal:  Front Immunol       Date:  2013-07-25       Impact factor: 7.561

10.  Intracellular interferons in fish: a unique means to combat viral infection.

Authors:  Ming-Xian Chang; Jun Zou; Pin Nie; Bei Huang; Zhanglong Yu; Bertrand Collet; Chris J Secombes
Journal:  PLoS Pathog       Date:  2013-11-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.